Atrys Health SL

Research Atrys Health SL (ATRY) on Bullrun: market cap EUR 192.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 192.04M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 141.01M-EUR 100.30M-EUR 14.08M43.5%n/aEUR 13.07MEUR 257.87MEUR 151.86M
FY2024EUR 129.98M-EUR 31.77M-EUR 10.14M50.4%-0.42EUR 20.37MEUR 255.40MEUR 253.10M
FY2023EUR 201.57M-EUR 45.59M-EUR 7.45M70.3%-0.6EUR 41.83MEUR 254.00MEUR 289.87M
FY2022EUR 158.37M-EUR 23.15M-EUR 30.60M79.6%-0.34EUR 34.30MEUR 241.22MEUR 336.40M
FY2021EUR 121.01M-EUR 23.24MEUR 471.00Kn/a-0.46EUR 35.13Mn/aEUR 272.63M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 192.04Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Atrys Health SL

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fields of radiology and cardiology;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Atrys Health SL's market cap?

Atrys Health SL's market capitalization is EUR 192.04M.

What does Atrys Health SL do?

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine.